From the Hoos article:
"Time is a luxury GSK can't afford right now."
That goes for all big pharmas. They need to stay ahead in the game. That's why I think vla will be eaten (or in a deal) within months.
As for imu, it's amazing that they have Hoos on-board (or is imu Hoos baby?).
Possible Buyer in the Wind, page-6
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)